Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1984 Apr 28;288(6426):1252–1253. doi: 10.1136/bmj.288.6426.1252

Acquired resistance to cancer chemotherapy.

P Selby
PMCID: PMC1441093  PMID: 6424816

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bertino J. R., Carman M. D., Weiner H. L., Cashmore A., Moroson B. A., Srimatkandada S., Schornagel J. H., Medina W. D., Dube S. K. Gene amplification and altered enzymes as mechanisms for the development of drug resistance. Cancer Treat Rep. 1983 Oct;67(10):901–904. [PubMed] [Google Scholar]
  2. Bonadonna G. Chemotherapy strategies to improve the control of Hodgkin's disease: the Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res. 1982 Nov;42(11):4309–4320. [PubMed] [Google Scholar]
  3. Carr F., Medina W. D., Dube S., Bertino J. R. Genetic transformation of murine bone marrow cells to methotrexate resistance. Blood. 1983 Jul;62(1):180–185. [PubMed] [Google Scholar]
  4. Cline M. J., Stang H., Mercola K., Morse L., Ruprecht R., Brown J., Salser W. Gene transfer in intact animals. Nature. 1980 Apr 3;284(5755):422–425. doi: 10.1038/284422a0. [DOI] [PubMed] [Google Scholar]
  5. Curt G. A., Carney D. N., Cowan K. H., Jolivet J., Bailey B. D., Drake J. C., Chien Song K. S., Minna J. D., Chabner B. A. Unstable methotrexate resistance in human small-cell carcinoma associated with double minute chromosomes. N Engl J Med. 1983 Jan 27;308(4):199–202. doi: 10.1056/NEJM198301273080406. [DOI] [PubMed] [Google Scholar]
  6. Goldie J. H., Coldman A. J. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1727–1733. [PubMed] [Google Scholar]
  7. Isaacs J. T., Coffey D. S. Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma. Cancer Res. 1981 Dec;41(12 Pt 1):5070–5075. [PubMed] [Google Scholar]
  8. Kaufman R. J., Brown P. C., Schimke R. T. Amplified dihydrofolate reductase genes in unstably methotrexate-resistant cells are associated with double minute chromosomes. Proc Natl Acad Sci U S A. 1979 Nov;76(11):5669–5673. doi: 10.1073/pnas.76.11.5669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. LAW L. W. Origin of the resistance of leukaemic cells to folic acid antagonists. Nature. 1952 Apr 12;169(4302):628–629. doi: 10.1038/169628a0. [DOI] [PubMed] [Google Scholar]
  10. Ling V., Kartner N., Sudo T., Siminovitch L., Riordan J. R. Multidrug-resistance phenotype in Chinese hamster ovary cells. Cancer Treat Rep. 1983 Oct;67(10):869–874. [PubMed] [Google Scholar]
  11. Luria S. E., Delbrück M. Mutations of Bacteria from Virus Sensitivity to Virus Resistance. Genetics. 1943 Nov;28(6):491–511. doi: 10.1093/genetics/28.6.491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. McElwain T. J., Powles R. L. High-dose intravenous melphalan for plasma-cell leukaemia and myeloma. Lancet. 1983 Oct 8;2(8354):822–824. doi: 10.1016/s0140-6736(83)90739-0. [DOI] [PubMed] [Google Scholar]
  13. Miller B. E., Miller F. R., Heppner G. H. Interactions between tumor subpopulations affecting their sensitivity to the antineoplastic agents cyclophosphamide and methotrexate. Cancer Res. 1981 Nov;41(11 Pt 1):4378–4381. [PubMed] [Google Scholar]
  14. Rubin J. S., Joyner A. L., Bernstein A., Whitmore G. F. Molecular identification of a human DNA repair gene following DNA-mediated gene transfer. Nature. 1983 Nov 10;306(5939):206–208. doi: 10.1038/306206a0. [DOI] [PubMed] [Google Scholar]
  15. Schabel F. M., Jr, Skipper H. E., Trader M. W., Laster W. R., Jr, Griswold D. P., Jr, Corbett T. H. Establishment of cross-resistance profiles for new agents. Cancer Treat Rep. 1983 Oct;67(10):905–922. [PubMed] [Google Scholar]
  16. Selby P. J., Thomas J. M., Peckham M. J. A comparison of the chemosensitivity of a primary tumour and its metastases using a human tumour xenograft. Eur J Cancer. 1979 Dec;15(12):1425–1429. doi: 10.1016/0014-2964(79)90020-3. [DOI] [PubMed] [Google Scholar]
  17. Valeriote F., van Putten L. Proliferation-dependent cytotoxicity of anticancer agents: a review. Cancer Res. 1975 Oct;35(10):2619–2630. [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES